17 min read
5.0
12

Perimenopause symptoms: the ones that might actually be something else

Most "perimenopause symptoms" really are perimenopause — but a specific subset can also be the first sign of POTS, ME/CFS, fibromyalgia, or MCAS.

Jane Smorodnikova
Founder & CEO
Mariia Podobed
Content Editor
Anna Elitzur
Medical Advisor
Hot flashes, mood changes, and joint pain are well-documented parts of perimenopause. But heart palpitations, crushing fatigue, widespread pain, and certain gut and skin reactions can also be the first signs of POTS, ME/CFS, fibromyalgia, or MCAS — conditions that routinely get absorbed into "it's just your hormones." In Welltory's own data, women who report both perimenopause and an energy-limiting condition carry the highest total number of diagnosed conditions of any group we can identify: 3.8 on average, versus 2.3 for an energy-limiting condition alone.

What perimenopause symptoms usually look like

If your mental picture of perimenopause is "hot flashes plus weird periods," you're not wrong — but you're missing the symptoms that often make people feel least like themselves. In a 2026 Mayo Clinic/Flo Health digital survey of 17,494 participants across 158 countries, the symptoms people most associated with perimenopause were hot flashes (71%), sleep problems (68%), and weight gain (65%). But among more than 12,000 participants over age 35, the most commonly reported symptoms were fatigue (83%), exhaustion (83%), irritability (80%), low mood (77%), sleep problems (76%), digestive issues (76%), and anxiety (75%). And among people who said they were in perimenopause, 95% reported exhaustion and 93% reported fatigue. Because this was an app-based, self-reported survey, those percentages describe that surveyed group — not every woman everywhere — but the pattern is still important: the symptom people expect is heat; the symptom many people live with is depletion. (Menopause / Hedges et al., 2026)

Pain belongs in the core picture too. A 2026 systematic review and meta-analysis of 37 observational studies across 22 countries, including 93,021 women, found that muscle or joint pain was reported by 40% of premenopausal women and 57% of perimenopausal women; in pairwise analysis, perimenopause was associated with a 1.35-fold higher risk of muscle or joint pain compared with premenopause. Sleep also shifts: a SWAN-focused review cites sleep disturbance prevalence of 16% to 42% in premenopause and 39% to 47% in perimenopause. And mental health symptoms are not just "stress": a UK Biobank analysis of nearly 125,000 participants found menopause was associated with higher levels of anxiety, depression, and sleep difficulty, while another UK Biobank study of 128,294 women found first-onset psychiatric disorders were more frequent during the perimenopause window than in the late reproductive reference period. (JBJS Open Access / Kruse et al., 2026; Cambridge/UK Biobank, 2026; Nature Mental Health / UK Biobank, 2024)

So the well-established center of "perimenopause symptoms" is broader than the classic checklist. It can include irregular periods, hot flashes, night sweats, trouble sleeping, mood swings, irritability, increased depression risk, vaginal and bladder changes, changing sexual function, and body-wide effects that track with fluctuating estrogen and progesterone. In the body, that hormonal volatility can touch sleep architecture, temperature regulation, connective tissue, pain sensitivity, mood circuits, and energy regulation — which is why perimenopause can feel like many systems wobbling at once, not one isolated reproductive event. (Mayo Clinic)

For most women, most of the time, this really is perimenopause: common, physiologic, and not "all in your head." The catch — and the reason this article exists — is that some symptoms in this same cluster can also be the first visible edge of another condition. The goal is not to doubt your hormones. It's to know when the pattern still fits perimenopause, and when your body is waving a second flag.


The diagnostic gap: why "it's just perimenopause" (and its mirror image, "it's just anxiety/getting older") both go unchecked

Here's the less-discussed part. The main research framework used to stage reproductive aging, STRAW+10, defines the menopausal transition by bleeding-pattern changes: early transition is marked by persistent cycle-length variability, and late transition by skipped cycles or 60+ days without bleeding. Symptoms are acknowledged, but they are not what "counts" for staging. That matters, because your nervous system, sleep, temperature regulation, mood, pain sensitivity, and heart-rate control can start reacting to hormone volatility before your calendar looks obviously "perimenopausal." (Harlow et al., STRAW+10)

A 2025 study in The Lancet Diabetes & Endocrinology looked at 8,096 Australian women aged 40–69, with 5,509 classified by STRAW+10. The authors found that vasomotor symptoms — hot flushes and night sweats — were the clearest symptom signal across the transition, but the standard STRAW+10 approach still relies on menstrual-cycle frequency, not symptoms. That means people with regular cycle timing are categorized as premenopausal regardless of symptom burden; the study also found that women with changed menstrual flow plus vasomotor symptoms, traditionally placed outside early perimenopause by STRAW+10, looked symptomatically similar to early perimenopausal women with vasomotor symptoms. In plain English: hallmark symptoms can show up before the cycle pattern is obvious enough to unlock the label. (The Lancet Diabetes & Endocrinology, 2025 — AMY Study00138-X/abstract))

The practical result of this gap runs in both directions. If you are in genuine early perimenopause but your periods still arrive on schedule, you may be told you are "too young," "still regular," or "just stressed," and your insomnia, anxiety, joint pain, palpitations, or brain fog may get treated as separate problems instead of as a body-wide transition. That is not imaginary: a UK primary-care study found higher rates of new anxiety and depressive-disorder diagnoses in women aged 45–54 than in men of the same age, and qualitative menopause studies describe women being dismissed, misdiagnosed, or offered antidepressants instead of hormone-focused assessment when symptoms were actually occurring in the perimenopausal window.

And the reverse happens too. Once you are recognizably in the perimenopausal age band — usually your 40s or 50s — there is a strong pull toward filing everything under "hormones." Fatigue, palpitations, dizziness, brain fog, gut reactions, flushing, widespread pain: all of these can overlap with perimenopause, but they can also be the presenting pattern of something else, especially when they have a distinct trigger signature. Symptoms that flare after standing, after exertion, after meals, after heat, after alcohol, or with rashes, diarrhea, faintness, or delayed "crash" deserve a second question: does this behave like perimenopause, or is perimenopause exposing another system that was already unstable?

The care-seeking gap is not small. A Mayo Clinic Proceedings study of nearly 5,000 women aged 45–60 found that approximately 87% did not seek medical care for menopause symptoms. Qualitative work also describes the reasons this happens from both sides: women may normalize symptoms as aging, feel embarrassed, lack information, or avoid care after a bad interaction; clinicians may miss less "classic" menopause symptoms, dismiss concerns, or fail to offer treatment options or referral when the case is more complex. So this section is not saying "don't attribute symptoms to perimenopause." It is saying: don't stop at the first plausible label. Ask what the symptom does in the body — when it starts, what triggers it, what relieves it, and whether its pattern points to a condition that can be tested and treated on its own. (Mayo Clinic Proceedings, 2026).

Why the overlap exists: perimenopause and ELC destabilize the same systems

This isn't coincidence. Estrogen is not just a reproductive hormone; it also helps tune nervous-system signaling. Estrogen receptors and sex-steroid-sensitive pathways show up in brainstem autonomic circuits, including relay centers for vagal input and downstream nuclei that help drive parasympathetic output to the heart. In plain English: the same chemistry that is changing during perimenopause also touches heart-rate control, vagal tone, baroreflexes, and stress reactivity. During perimenopause, ovarian function fluctuates significantly, and FSH and estradiol can vary enough that single lab results may be hard to interpret; this is not a smooth "estrogen slowly fades" process. It is a moving target. (PMC review, estrogen and autonomic circuits)

That matters because POTS, ME/CFS, fibromyalgia, and MCAS already sit in overlapping autonomic, neuroendocrine, immune, and pain-processing territory. POTS is defined as a chronic autonomic disorder with orthostatic tachycardia; ME/CFS is described by NIH and CDC as a systemic illness involving neurological, immunological, autonomic, and energy-metabolism dysfunction, with some patients showing HPA-axis dysregulation; fibromyalgia research points to increased sympathetic tone and possible HPA-axis involvement; and mast-cell disorders can come with orthostatic intolerance, pain, cognitive symptoms, and mild-to-moderate autonomic dysfunction. So if your system was already spending extra energy keeping blood flow, inflammation, sleep, pain, and stress responses stable, perimenopause can remove some of the buffer. Symptoms can intensify not because "it's all hormones," but because hormones are one of the things your autonomic and stress-response systems were using to stay upright.

Rising FSH may add another layer. Human midlife data have linked FSH and LH with worse verbal episodic memory measures, while a study of women ages 40–65 at elevated Alzheimer's risk found higher gonadotropins associated with increased Alzheimer's biomarker risk independent of regional estradiol effects. That does not mean perimenopause brain fog is Alzheimer's disease, or that FSH testing explains your symptoms. It means brain fog during this window has plausible biology beyond "you're distracted" or "you're stressed," and that biology can stack on top of POTS, ME/CFS, fibromyalgia, or MCAS instead of replacing them.

None of this makes perimenopause "the same as" an energy-limiting condition. It means the two can plausibly compound each other. A body already managing one autonomic or neuroimmune load has less spare capacity when another major regulator starts fluctuating. That is why the question is not "hormones or something else?" The better question is: which systems are being pushed at the same time, and which symptoms are too intense, too positional, too exertion-linked, too allergic-looking, or too persistent to file under perimenopause alone?

The symptom-by-symptom differential: what to notice

None of the patterns below are self-diagnosis tools. They're the specific, describable features that make a symptom worth raising with a clinician as possibly more than perimenopause — the kind of detail that's easy to miss if "hormones" already feels like a sufficient explanation.

Heart racing, palpitations, dizziness on standing A perimenopausal hot flash is usually a heat-led event: a sudden flare of warmth, sweating, flushing, sometimes chills, and sometimes a faster heartbeat. Typical hot flashes last about one to five minutes, and physiologic studies show the heart-rate rise during a hot flash is usually modest — often around 7–15 bpm. POTS looks different because posture is the organizing clue. Consensus criteria describe a sustained heart-rate rise of at least 30 bpm within 10 minutes of standing or head-up tilt in adults — at least 40 bpm in ages 12–19 — along with orthostatic symptoms and no significant orthostatic blood-pressure drop; symptoms typically improve rapidly when the person lies back down. If it's consistently the standing up that triggers the racing heart, dizziness, trembly weakness, or "I need to lie down now" feeling — not a wave of heat — that's the detail worth naming to a clinician.

Overwhelming fatigue and brain fog This is the symptom with the most genuine overlap. Perimenopause can disturb sleep through night sweats, insomnia, early waking, mood changes, and pain. ME/CFS and long COVID can also bring fatigue and brain fog, but the distinguishing feature is not simply being tired — it's what happens after exertion. Post-exertional malaise, or PEM, is a worsening of symptoms after physical, cognitive, or emotional effort that would previously have been tolerated; CDC guidance describes symptoms as typically worsening 12–48 hours after activity and lasting days or even weeks. Cognitive research around menopause is also mixed in a way that matters clinically: some longitudinal and meta-analytic studies find subtle, stage-related cognitive changes during the transition, while a large UK Biobank cohort found that self-reported brain fog and poor memory were only weakly tied to objective memory-test performance. So the question is practical: does a bad night's sleep explain today's fatigue, or did yesterday's activity — a longer walk, errands, a stressful meeting, a big emotional day — seem to cause today's crash?

Widespread pain, new joint or muscle pain Perimenopause-related joint and muscle pain is real and common — the same meta-analysis of 93,021 women cited above found muscle or joint pain in about 40% of premenopausal women, rising to 57% in perimenopausal women and 59% in postmenopausal women. Similar-sounding symptoms can also be characteristic of fibromyalgia, so it's worth understanding what actually sets it apart. Fibromyalgia is a different kind of pattern: a long-term pain-processing condition in which the nervous system becomes more sensitive to pain signals, usually with widespread pain plus fatigue, unrefreshing sleep, and cognitive symptoms sometimes called "fibro fog." Formal fibromyalgia criteria use tools such as the Widespread Pain Index and Symptom Severity Scale, require generalized pain in multiple body regions, and require symptoms to have been present for at least three months. If pain is genuinely everywhere, unrelenting, and traveling with the same fatigue-sleep-brain-fog cluster rather than rising and falling with other perimenopausal symptoms, that combination deserves a specific conversation.

Digestive symptoms, skin flushing/hives, sudden reactions to food or heat Perimenopause can affect the gut. Sex hormones interact with GI motility, the gut barrier, inflammation, and the microbiome, and peri- and postmenopausal women can report IBS-like symptoms such as altered bowel function, bloating, constipation, diarrhea, heartburn, or abdominal discomfort. These same digestive and skin symptoms can also be a sign of MCAS (mast cell activation syndrome) — here's the difference worth knowing. MCAS is not "a sensitive gut plus brain fog." It is a much narrower and debated diagnosis that requires repeated episodes affecting at least two organ systems, objective evidence of mast-cell activation such as tryptase changes during a flare, and clinical response to mast-cell–targeted treatment; symptoms alone are not enough. The pattern that makes mast-cell activation worth discussing is more allergic-type and episodic: flushing, itching, hives or swelling, abdominal cramping, diarrhea or vomiting, wheezing, low blood pressure, faintness, or a racing heart occurring together, sometimes after triggers such as foods, medications, alcohol, heat/cold shifts, stings, stress, or strong environmental exposures. One reason MCAS can flare specifically around perimenopause: mast cells carry their own estrogen and progesterone receptors, and progesterone — which helps stabilize mast cell membranes — typically starts declining earlier and more steeply than estrogen, removing some of that stabilizing brake right as estrogen itself becomes more erratic. If there's a repeatable trigger-to-reaction pattern involving skin plus gut, breathing, or cardiovascular symptoms, that is different from a generally more sensitive gut. (Zaitsu et al., estradiol and mast cell activation; Frontiers in Immunology — sex hormones and mast cell behavior)

Nighttime episodes: hot flashes vs. something else A classic perimenopausal night sweat is heat-led: sudden warmth, sweating, flushed or clammy skin, sometimes palpitations, then the episode passes. Waking with a fast heart rate and dizziness that is not clearly heat-led — especially if it happens when you sit up or stand to use the bathroom — points more toward an autonomic or orthostatic pattern than a pure vasomotor one. The useful detail is the sequence: heat first, then sweat and heart rate; or posture first, then dizziness, weakness, and racing heart.

None of these distinctions are diagnostic on their own, and several of these conditions can overlap in the same body. POTS patients may also meet criteria for conditions such as chronic fatigue syndrome, fibromyalgia, migraine, hEDS, or MCAS. A real differential diagnosis requires a clinician and often specific testing: active stand or tilt-table assessment for POTS, tryptase and other mediator testing for suspected mast-cell activation, Widespread Pain Index/Symptom Severity scoring for fibromyalgia, and a careful PEM history plus exclusion of other causes for ME/CFS. This section is meant to help you describe your symptoms more precisely to a doctor, not to replace that evaluation.

What we see in Welltory's own data

In Welltory's anonymized user data, the heaviest health load shows up in the group that reports both perimenopause and an energy-limiting condition — ME/CFS, POTS, fibromyalgia, or long COVID. These are not the same illness, and they should not be flattened into one label. But they can all touch the same daily-life systems people often blame on hormones alone: energy, pain, sleep, cognition, standing tolerance, heart-rate sensations, and the ability to recover after exertion.

That overlap matters because, in our data, women who report both perimenopause and one of these energy-limiting conditions carry the highest total number of diagnosed conditions of any group we can identify: 3.8 conditions on average, compared with 2.3 for women with an energy-limiting condition alone, and well above the 0.4–1.6 average for women with neither or only one condition (n=888 perimenopause+ELC users vs. n=2,082 ELC-only users, self-reported survey data from Welltory's user base, generated 2026-07-22).

So this is not just a "more symptoms" group. It is a more-to-untangle group. If your body is already managing dysautonomia, post-exertional crashes, widespread pain, or post-viral symptoms, perimenopause can make the picture louder without being the whole explanation. The practical question becomes: is this a hormone-transition pattern, a flare of something you already have, or a new problem that deserves its own workup? For this group, getting that question right can change what gets tracked, what gets tested, and what kind of care actually helps.

All figures in this section are reported as anonymized, aggregated data drawn from self-reported user surveys; this is observational, cross-sectional data — not a diagnosis and not a controlled clinical study — and no individual user is identifiable.

What actually helps you tell the difference — and go check

You don't have to guess from vibes alone. The useful move is to turn "I feel awful" into a pattern you can actually show someone: what your heart rate did when you stood up, whether your recovery dipped after exertion, whether the crash came the next day, and whether the same trigger keeps producing the same body response.

Start with the Orthostatic Test in Science Lab. It's a guided sit-to-stand heart-rate check: you measure your heart rate seated, then again at set intervals after standing. That matters because the POTS-type question is not simply "do I get palpitations?" — it's "do palpitations, dizziness, brain fog, shakiness, or fatigue reliably show up when my body is upright?" Welltory's test is not a diagnosis, but it can give you a concrete five-minute pattern to bring into the room instead of trying to describe "sometimes my heart races."

Then look at your HRV report and Health Score as a trend, not a verdict. One low morning reading can happen for boring reasons: poor sleep, alcohol, stress, travel, a hard workout, a hot night. The more useful question is whether your recovery keeps staying low even after a decent night's sleep and a quiet day. Perimenopause can absolutely disrupt sleep and leave you tired or foggy. But if your recovery metrics stay suppressed in a repeated, non-random way — especially alongside dizziness, palpitations, or delayed crashes — that is a different conversation to have with a clinician.

Use the Battery report for the timing question. Perimenopausal bad days often make intuitive sense when you map them to the night before: hot flashes, fragmented sleep, stress, a cycle change. PEM-style crashes are sneakier — symptoms worsen after activity, are often delayed by hours or days, and feel out of proportion to what you did. So if your Battery curve tanks after yesterday's grocery run, work meeting, workout, social event, or long drive — not immediately, but later — that timing is worth writing down.

Use Journal and tags for the details your memory will not reliably keep. Tag standing, heat, meals, alcohol, poor sleep, exertion, stress, skin flushing, GI symptoms, pain flares, and cycle day if you still have periods. Add the boring specifics: "started 6 hours after activity," "worse after shower," "heart racing while standing in line," "better lying down," "crashed the next morning." This is the raw material for the real question: not "is this perimenopause or something else?" but "does my body keep repeating the same pattern?"

These tools surface patterns worth discussing with a clinician — they don't diagnose POTS, ME/CFS, fibromyalgia, or MCAS. Consumer heart-rate and HRV measurement carries a real margin of error against clinical-grade testing. Frame any of this as "here's a pattern I noticed, can we look into it" — never as "my wearable confirmed X."

If what you're noticing lines up more with the energy-limiting-condition side of this — especially the PEM or delayed-crash pattern — our companion piece on perimenopause and energy-limiting conditions goes deeper into that overlap, including Energy Lab, Welltory's community for people living with ME/CFS, POTS, fibromyalgia, and long COVID, where perimenopause increasingly comes up as its own shared topic among members.

How we made it

Made with AI tools, then edited, fact-checked, and medically reviewed by the Welltory team.

You're not imagining it. And you're not alone.

This article is for educational purposes and does not replace medical advice. If you have new, severe, or worsening symptoms, talk with a healthcare professional.

Was this helpful?

Ask AI for a summary of page

ChatGPTGeminiClaudePerplexityGrok

Written by Jane Smorodnikova

The founder and CEO of Welltory. A recognized tech leader with two Master's degrees and experience at MIT, she has scaled Welltory to over 17 million users.

Written by Mariia Podobed

Carefully explores the lived experience of chronic conditions, transforming it into clear, accessible content that helps people find understanding, support, and answers.

Reviewed by Anna Elitzur

With her medical degree, Anna reviews Welltory's health content for medical accuracy and alignment with current clinical guidelines and research.

References

  1. Hedges MS, Hewings-Martin Y, Karam J, et al. "Global perspectives on perimenopause: a digital survey of knowledge and symptoms using the Flo application." Menopause. 2026. https://pubmed.ncbi.nlm.nih.gov/41603602/
  2. Zuhlsdorff K, et al. "Emotional and cognitive effects of menopause and hormone replacement therapy." UK Biobank analysis, ~125,000 participants. Psychological Medicine. 2026. https://pubmed.ncbi.nlm.nih.gov/41587742/
  3. Kruse C, McKechnie T, Dworsky-Fried J, et al. "Musculoskeletal Manifestations of Perimenopause: A Systematic Review and Meta-Analysis of 93,021 Women." JBJS Open Access. 2026;11(1):e25.00254. https://pmc.ncbi.nlm.nih.gov/articles/PMC12784006/
  4. "Prevalence and severity of symptoms across the menopause transition: cross-sectional findings from the Australian Women's Midlife Years (AMY) Study." The Lancet Diabetes & Endocrinology. 2025;13(9):727-728. https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00138-X/abstract
  5. Harlow SD, Gass M, Hall JE, et al. "Executive summary of the Stages of Reproductive Aging Workshop + 10." STRAW+10 staging framework. https://pmc.ncbi.nlm.nih.gov/articles/PMC3580996/
  6. "Exploration of first onsets of mania, schizophrenia spectrum disorders and major depressive disorder in perimenopause." Nature Mental Health. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11479941/
  7. Kapoor E, et al. "Addressing Menopause Symptoms: Barriers and Opportunities for Improvement." Mayo Clinic Proceedings. 2025 — care-seeking gap study, ~5,000 women aged 45-60. https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-study-finds-majority-of-midlife-women-with-menopause-symptoms-do-not-seek-care/
  8. Mayo Clinic. "Perimenopause — Symptoms and causes." https://www.mayoclinic.org/diseases-conditions/perimenopause/symptoms-causes/syc-20354666
  9. "Sex-steroid-dependent plasticity of brain-stem autonomic circuits." American Journal of Physiology. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7468793/
  10. Dobbs WC, Fedewa MV, MacDonald HV, et al. "The Accuracy of Acquiring Heart Rate Variability from Portable Devices: A Systematic Review and Meta-Analysis." Sports Medicine. 2019;49(3):417-435. https://pubmed.ncbi.nlm.nih.gov/30706234/
  11. Zaitsu M, et al. "Estradiol activates mast cells via a non-genomic estrogen receptor-α and calcium influx." Molecular Immunology. 2007. https://www.sciencedirect.com/science/article/abs/pii/S0161589006006262
  12. Vasiadi M, et al. "Role of female sex hormones, estradiol and progesterone, in mast cell behavior." Frontiers in Immunology. 2012. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2012.00169/full
  13. Welltory internal cohort analysis: `perimenopause__energy_limiting_conditions__cohort.json` (n=888 perimenopause+ELC, n=2,082 ELC-only, self-reported survey + wearable data).

FAQ